National Institute of Arthritis and Musculoskeletal and Skin Diseases logo
NIAMS SBIR/STTR

NIAMS SBIR — Small Business Innovation Research

Supports small businesses and researchers advancing arthritis, skin, and musculoskeletal innovation through staged aid.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) SBIR program (R43/R44) funds U.S. small businesses developing innovative research with commercialization potential in NIAMS's three core disease domains: arthritis and rheumatic diseases, musculoskeletal and bone disorders, and skin conditions. NIAMS administers the program within the NIH-wide SBIR framework, and app

Small business innovation research with commercialization potential in arthritis, rheumatic diseases, musculoskeletal disorders, bone and muscle biology, and skin diseases.

CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Multiple per year
Next deadlineiThe next date applications are due. Rolling means you can apply any time.
Decision timeiTypical time from the deadline to the funder's decision.
Project durationiHow long the funded work is expected to run.
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see the timeline

Last verified: 22 Jul 2026Source: www.niams.nih.gov